Blog
About

22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Identification of a primary target of thalidomide teratogenicity.

      Science (New York, N.Y.)

      Animals, Carrier Proteins, metabolism, Chick Embryo, Cullin Proteins, DNA-Binding Proteins, Embryo, Nonmammalian, drug effects, Embryonic Development, Fibroblast Growth Factors, genetics, Forelimb, abnormalities, embryology, Gene Expression Regulation, Developmental, HeLa Cells, Humans, Mutant Proteins, Peptide Hydrolases, Teratogens, toxicity, Thalidomide, Ubiquitin-Protein Ligases, antagonists & inhibitors, Ubiquitination, Zebrafish, Zebrafish Proteins

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects. Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown. Here, we identified cereblon (CRBN) as a thalidomide-binding protein. CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity. This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivatives without teratogenic activity.

          Related collections

          Author and article information

          Journal
          20223979
          10.1126/science.1177319

          Comments

          Comment on this article